USFDA completes inspection at Strides Pharma Science’s Chennai facility
9th Aug 2019

Strides Pharma Science’s formulations facility at at Alathur (Chennai) has underwent a US Food and Drug Administration (USFDA) inspection starting August 05, 2019 and the inspection concluded August 9, 2019 with “Zero 483 observations”. 

The Alathur facility became part of the Strides manufacturing base in May 2017 after the Company entered into a 50:50 joint venture (JV) with Vivimed Labs in March 2019. The company converted its ownership in JV to 100% to take full management and operational control of this manufacturing facility. 

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.